Newsroom

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Read press release

Worldwide Water Warriors

Battling the issues of water safety – one of the greatest global challenges of our time